The FIT kit, which checks for blood in a stool sample, is a crucial tool in detecting early signs of bowel cancer.

While the bowel cancer screening programme will cover those aged 50 to 74, anyone aged 75 and over can request a kit by ...

Correspondence to Dr Tony Hsiu-Hsi Chen, Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei 100, Taiwan; chenlin{at}ntu.edu.tw Objective To ...

Around 850,000 people aged 50 and 52 will receive a bowel cancer testing kit in the post as the NHS extends its screening ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Fecal Immunochemical Diagnostic Test (FIT) Market The FIT market is growing due to increased awareness and adoption of non-invasive colorectal cancer screening options. WILMINGTON, DE, UNITED STATES,.

Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this ...

A groundbreaking blood test for colorectal cancer screening has received approval from the U.S. Food and Drug Administration (FDA), offering the potential to revolutionize early detection for one ...

Jochim S Terhaar sive Droste; Sietze T van Turenhout; Frank A Oort; René WM van der Hulst; Vincent A Steeman; Usha Coblijn; Lisette van der Eem; Ruud Duijkers; Anneke A Bouman; Gerrit A Meijer ...

NEW YORK – Sysmex America said Monday that it has inked a deal with Sentinel Diagnostics to distribute and service in Canada two Sentinel instruments for fecal immunochemical testing. In a statement, ...

In the present study, test accuracy of one of the most commonly used FITs was evaluated in a large cohort of asymptomatic, high-risk individuals undergoing colonoscopy surveillance. It was found ...